JOHNSON MWANGI: Open Payments
NPI 1578748505 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,873 in 69 payments from 17 companies in 2025. Trend: 2023 $1,252 · 2024 $1,412 · 2025 $1,873
Food & beverage: $1,674Education: $199
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $529 |
| Regeneron Healthcare Solutions, Inc. | 13 | $280 |
| Lilly USA, LLC | 8 | $197 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $193 |
| UCB, Inc. | 5 | $107 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| ABBVIE INC. | 5 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Galderma Laboratories, L.P. | 3 | $49 |
| PFIZER INC. | 2 | $49 |
Products named: DUPIXENT, TALTZ, Bimzelx, ILUMYA, COSENTYX, RINVOQ, CIBINQO, OPZELURA.
Industry payments across TX — which companies pay providers there.
